87 related articles for article (PubMed ID: 30629682)
21. Mice deficient for the type II topoisomerase-like DNA transesterase Spo11 show normal immunoglobulin somatic hypermutation and class switching.
Klein U; Esposito G; Baudat F; Keeney S; Jasin M
Eur J Immunol; 2002 Feb; 32(2):316-21. PubMed ID: 11807770
[TBL] [Abstract][Full Text] [Related]
22. DNA repair kinetics in SCID mice Sertoli cells and DNA-PKcs-deficient mouse embryonic fibroblasts.
Ahmed EA; Vélaz E; Rosemann M; Gilbertz KP; Scherthan H
Chromosoma; 2017 Mar; 126(2):287-298. PubMed ID: 27136939
[TBL] [Abstract][Full Text] [Related]
23. Tirapazamine: a hypoxia-activated topoisomerase II poison.
Peters KB; Brown JM
Cancer Res; 2002 Sep; 62(18):5248-53. PubMed ID: 12234992
[TBL] [Abstract][Full Text] [Related]
24. Rad52 competes with Ku70/Ku86 for binding to S-region DSB ends to modulate antibody class-switch DNA recombination.
Zan H; Tat C; Qiu Z; Taylor JR; Guerrero JA; Shen T; Casali P
Nat Commun; 2017 Feb; 8():14244. PubMed ID: 28176781
[TBL] [Abstract][Full Text] [Related]
25. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
26. Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway.
Zhang Y; Johansson E; Miller ML; Jänicke RU; Ferguson DJ; Plas D; Meller J; Anderson MW
PLoS One; 2011; 6(9):e25284. PubMed ID: 21980415
[TBL] [Abstract][Full Text] [Related]
27. Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells.
Kizaki H; Onishi Y
Adv Enzyme Regul; 1997; 37():403-23. PubMed ID: 9381984
[TBL] [Abstract][Full Text] [Related]
28. Single-strand DNA breaks in Ig class switch recombination that depend on UNG but not AID.
Arudchandran A; Bernstein RM; Max EE
Int Immunol; 2008 Nov; 20(11):1381-93. PubMed ID: 18794203
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin class switch recombination is impaired in Atm-deficient mice.
Lumsden JM; McCarty T; Petiniot LK; Shen R; Barlow C; Wynn TA; Morse HC; Gearhart PJ; Wynshaw-Boris A; Max EE; Hodes RJ
J Exp Med; 2004 Nov; 200(9):1111-21. PubMed ID: 15504820
[TBL] [Abstract][Full Text] [Related]
30. Non-canonical uracil processing in DNA gives rise to double-strand breaks and deletions: relevance to class switch recombination.
Bregenhorn S; Kallenberger L; Artola-Borán M; Peña-Diaz J; Jiricny J
Nucleic Acids Res; 2016 Apr; 44(6):2691-705. PubMed ID: 26743004
[TBL] [Abstract][Full Text] [Related]
31. The requirement of Artemis in double-strand break repair depends on the type of DNA damage.
Kurosawa A; Koyama H; Takayama S; Miki K; Ayusawa D; Fujii M; Iiizumi S; Adachi N
DNA Cell Biol; 2008 Jan; 27(1):55-61. PubMed ID: 17941805
[TBL] [Abstract][Full Text] [Related]
32. Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.
Senturk JC; Bohlman S; Manfredi JJ
Oncogene; 2017 Nov; 36(44):6085-6096. PubMed ID: 28692049
[TBL] [Abstract][Full Text] [Related]
33. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
[TBL] [Abstract][Full Text] [Related]
34. Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.
Sabourin M; Nitiss JL; Nitiss KC; Tatebayashi K; Ikeda H; Osheroff N
Nucleic Acids Res; 2003 Aug; 31(15):4373-84. PubMed ID: 12888496
[TBL] [Abstract][Full Text] [Related]
35. Redundant function of DNA ligase 1 and 3 in alternative end-joining during immunoglobulin class switch recombination.
Masani S; Han L; Meek K; Yu K
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1261-6. PubMed ID: 26787901
[TBL] [Abstract][Full Text] [Related]
36. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M
Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762
[TBL] [Abstract][Full Text] [Related]
37. The DNA Ligase IV Syndrome R278H Mutation Impairs B Lymphopoiesis via Error-Prone Nonhomologous End-Joining.
Park J; Welner RS; Chan MY; Troppito L; Staber PB; Tenen DG; Yan CT
J Immunol; 2016 Jan; 196(1):244-55. PubMed ID: 26608917
[TBL] [Abstract][Full Text] [Related]
38. Combined treatment with temozolomide and methoxyamine: blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIalpha.
Yan L; Bulgar A; Miao Y; Mahajan V; Donze JR; Gerson SL; Liu L
Clin Cancer Res; 2007 Mar; 13(5):1532-9. PubMed ID: 17332299
[TBL] [Abstract][Full Text] [Related]
39. DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions.
Panchakshari RA; Zhang X; Kumar V; Du Z; Wei PC; Kao J; Dong J; Alt FW
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):762-767. PubMed ID: 29311308
[TBL] [Abstract][Full Text] [Related]
40. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination.
Manis JP; Morales JC; Xia Z; Kutok JL; Alt FW; Carpenter PB
Nat Immunol; 2004 May; 5(5):481-7. PubMed ID: 15077110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
